Many of the 12q fusion genes produced chimeric proteins or disrupted cancer-associated genes such as RUNX2, CCND3, and LRP1, indicating that some of the fusions may contribute to cancer progression independently of MDM2/CDK4 co-amplification. This evidence concerns the gene RUNX2 and cancer.